Lloyd Tanner
Impact in
-
- Tuberculosis Research and Epidemiology
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neonatal Respiratory Health Research
- Inhalation and Respiratory Drug Delivery
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Neonatal Respiratory Health Research 3
- Respiratory Support and Mechanisms 2
-
- Cancer therapeutics and mechanisms 6
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Co-authors
- Andrew Single (4 shared papers)Lubbe Wiesner (5 shared papers)Richard K. Haynes (4 shared papers)Arne Egesten (9 shared papers)Digby F. Warner (3 shared papers)István Boldogh (6 shared papers)Lang Pan (6 shared papers)Ravi K. V. Bhongir (7 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)Frontiers in Immunology (3 papers)Journal of Innate Immunity (2 papers)Immunology (1 paper)ACS Omega (1 paper)
- Partner nations
- SwedenUnited StatesSouth Africa
In The Last Decade
Lloyd Tanner
20 papers receiving 333 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 63
- Pulmonary and Respiratory Medicine 107
- Toxicology 11
- Immunology 51
- Molecular Biology 144
Countries citing papers authored by Lloyd Tanner
This map shows the geographic impact of Lloyd Tanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Tanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Tanner more than expected).
Fields of papers citing papers by Lloyd Tanner
This network shows the impact of papers produced by Lloyd Tanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Tanner. The network helps show where Lloyd Tanner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lloyd Tanner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 75 | |
| 2 | 2023 | 52 | |
| 3 | 2019 | 25 | |
| 4 | 2018 | 24 | |
| 5 | 2023 | 22 | |
| 6 | 2022 | 18 | |
| 7 | 2019 | 16 | |
| 8 | 2020 | 15 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2020 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2024 | 2 | |
| 20 | 1992 | 1 |
About Lloyd Tanner
Lloyd Tanner is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Infectious Diseases, Oncology and Epidemiology, having authored 20 papers that have together received 335 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), Tuberculosis Research and Epidemiology (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Neonatal Respiratory Health Research (3 papers), Respiratory Support and Mechanisms (2 papers), Asthma and respiratory diseases (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Infectious Diseases (63 citations), Pulmonary and Respiratory Medicine (107 citations), Toxicology (11 citations), Immunology (51 citations) and Molecular Biology (144 citations). Lloyd Tanner has collaborated with scholars based in Sweden, United States and South Africa. Frequent co-authors include Andrew Single, Lubbe Wiesner, Richard K. Haynes, Arne Egesten, Digby F. Warner, István Boldogh, Lang Pan, Ravi K. V. Bhongir, Paolo Denti and Cecilia Andersson. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Immunology, Journal of Innate Immunity, Immunology and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.